Warm ischemia provokes inflammation and regional hypercoagulability within the heart during off-pump coronary artery bypass: a possible target for serine protease inhibition

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 2, 2008, Pages 215-221

  Kon, Zachary N ^a   Brown, Emile N ^a   Grant, Michael C ^a   Ozeki, Toshinaga ^a   Burris, Nicholas S ^a   Collins, Michael J ^a   Kwon, Michael H ^a   Poston, Robert S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Aprotinin; Coronary artery bypass; Hypercoagulabilty; Ischemia; OPCAB

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFIBRINOLYTIC AGENT; ANTITHROMBOCYTIC AGENT; APROTININ; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 12; INTERLEUKIN 8; MYOGLOBIN; PROTAMINE; SERINE PROTEINASE; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTERIAL BLOOD; ARTICLE; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS BLOOD FLOW; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HEPARINIZATION; HUMAN; HYPERCOAGULABILITY; INFLAMMATION; MALE; MORNING DOSAGE; OFF PUMP CORONARY SURGERY; PH; PLATELET MICROPARTICLE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBIN TIME; THROMBOSIS;

ACIDOSIS; AGED; APROTININ; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MYOCARDITIS; MYOGLOBIN; PLATELET ACTIVATION; PROSPECTIVE STUDIES; SERINE PROTEINASE INHIBITORS; THROMBOPHILIA; THROMBOSIS; TUMOR NECROSIS FACTOR-ALPHA; WARM ISCHEMIA;

EID: 38349082676     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.11.008     Document Type: Article

References (26)

1. Nathoe H.M., Buskens E., Jansen E.W.L., Suyker W.J.L., Stella P.R., Lahpor J.R., van Boven W.-J., van Dijk D., Diephuis J.C., Borst C., Moons K.G.M., Grobbee D.E., and de Jaegere P.P.T. Role of coronary collaterals in off-pump and on-pump coronary bypass surgery. Circulation 110 (2004) 1738-1742
2. Puskas J.D., Williams W.H., Duke P.G., Staples J.R., Glas K.E., Marshall J.J., Leimbach M., Huber P., Garas S., Sammons B.H., McCall S.A., Petersen R.J., Bailey D.E., Chu H., Mahoney E.M., Weintraub W.S., and Guyton R.A. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial Injury, transfusion requirements and length of stay: a prospective randomized comparison comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 797-808
3. Ascione R., Williams S., Lloyd C.T., Sundaramoorthi T., Pitsis A.A., and Angelini G.D. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 121 (2001) 689-696
4. Nuttall G.A., Erchul D.T., Haight T.J., Ringhofer S.N., Miller T.L., Oliver W.C., Zehr K.J., and Schroeder D.R. A comparison of bleeding and transfusion in patients who undergo coronary artery bypass grafting via sternotomy with and without cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 (2003) 447-451
5. Kon Z.N., Kwon M.H., Collins M.J., Kallam S., Sangrampurkar R., Ozeki T., Brown E.N., Romar L.G., Pierson R.N., Gammie J.S., Brown J.M., Griffith B.P., and Poston R.S. Off-pump coronary artery bypass leads to a regional hypercoagulable state not detectable using systemic markers. Innovations 1 (2006) 232-238
6. Becker R.C., Spencer F.A., Li Y., Ball S.P., Ma Y., Hurley T., and Hebert J. Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential. J Am Coll Cardiol 34 4 (1999) 1020-1027
7. Poston R.S., Gu J., Brown J.M., Gammie J.S., White C., Nie L., Pierson R.N., and Griffith B.P. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 131 1 (2006) 122-130
8. Raivio P., Kuitunen A., Suojaranta-Ylinen R., Lassila R., and Petaja J. Thrombin generation during reperfusion after coronary artery bypass surgery associates with postoperative myocardial damage. J Thromb Haemost 4 7 (2006) 1523-1529
9. Eikelboom J.W., Weitz J.I., Budajd A., Zhaoe F., Coplande I., Maciejewskid P., Johnstonb M., and Yusufet S. Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. Eur Heart J 23 22 (2002) 1771-1779
10. Merlini P.A., Repetto A., Andreoli A.M., Ricci S., Lombardi A., Finardi A., Dipasquale G., Lamponi M., Mannucci P.M., and Ardissino D. Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase. Am J Cardiol 93 2 (2004) 195-198
11. Despotis G.J., Gravlee G., Filos K., and Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 91 4 (1999) 1122-1131
12. Landis R.C., Asimakopoilos G., Poullis M., Haskard D.O., and Taylor K.M. The antithrombotic and anti-inflammatory mechanisms of action of aprotinin. Ann Thorac Surg 72 (2001) 2169-2175
13. Dietrich W. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?. J Cardiovasc Pharmacol 27 Suppl. 1 (1996) S50-S57
14. Khan T.A., Bianchi C., Voisine P., Sandmeyer J., Feng J., and Sellke F.W. Aprotinin inhibits protease-dependent platelet aggregation and thrombosis. Ann Thorac Surg 79 5 (2005) 1545-1550
15. Poston R.S., White C., Gu J., Brown J., Gammie J., Pierson R.N., Lee A., Connerney I., Avari T., Christenson R., Tandry U., and Griffith B.P. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. Ann Thorac Surg 81 (2006) 104-110
16. Moliterno D.J. Results of a multinational randomized, double-blind, Placebo-controlled study of a novel thrombin receptor antagonist SCH 530348 in percutaneous coronary intervention. American College of Cardiology meeting. New Orleans, March 24th (2007)
17. Shore-Lesserson L., Manspeizer H.E., DePerio M., Francis S., Vela-Cantos F., and Ergin M.A. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88 (1999) 312-319
18. Nieuwland R., Berckmans R.J., Rotteveel-Eijkman R.C., Maquelin K.N., Roozendaal K.J., Jansen P.G., ten Have K., Eijsman L., Hack C.E., and Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96 (1997) 3534-3541
19. Roberts R., and Fromm R.E. Management of acute coronary syndromes based on risk stratification by biochemical markers: an idea whose time has come. Circulation 98 18 (1998) 1831-1833
20. Scharn D.M. Activation of platelets in blood perfusing angioplasty damaged coronary arteries. Cardiovasc Surg 10 (2002) 566
21. Laskey W.K., Zawacki K., Lim R., and Herzog W. Effects of local heparin administration on coronary thrombin activity during percutaneous transluminal coronary angioplasty. Catheter Cardiovasc Interv 48 1 (1999) 84-88
22. Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
23. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
24. Henry D.A., Carless P., Moxey A., O'connell D., Stokes B., McClelland B., Laupacis A., and Fergusson D. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 4 (2007) CD001886
25. Dygert J.H., Thatte H.S., Kumbhani D.J., Najjar S.F., Treanor P.R., and Khuri S.F. Intracoronary shunt-induced endothelial cell damage in porcine heart. J Surg Res 131 2 (2006) 168-174
26. Wolberg A.S., Meng Z.H., Monroe D.M., and Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56 6 (2004) 1221-1228